The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Dec. 22, 2020

Filed:

Oct. 30, 2017
Applicant:

Merck Sharp & Dohme Corp., Rahway, NJ (US);

Inventors:

Brendan M. Crowley, Collegeville, PA (US);

Ian M. Bell, Harleysville, PA (US);

Andrew John Harvey, Paddington, AU;

William D. Shipe, Chalfont, PA (US);

Kenneth J. Leavitt, Mount Laurel, NJ (US);

John M. Sanders, Hatfield, PA (US);

Deodial G. Guiadeen, Chesterfield, NJ (US);

Linda M. Suen, Philadelphia, PA (US);

Thomas J. Greshock, Collegeville, PA (US);

Vanessa L. Rada, Hatfield, PA (US);

Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
C07D 263/56 (2006.01); A61K 31/498 (2006.01); C07D 239/74 (2006.01); C07D 241/42 (2006.01); C07D 265/16 (2006.01); C07D 277/68 (2006.01); C07D 471/04 (2006.01); C07D 487/04 (2006.01); C07D 498/04 (2006.01); A61K 31/4375 (2006.01); A61K 31/5383 (2006.01); A61K 31/416 (2006.01); A61K 31/428 (2006.01); A61K 31/4365 (2006.01); A61K 31/502 (2006.01); A61K 31/4162 (2006.01); A61K 45/06 (2006.01); C07D 231/56 (2006.01); A61K 31/536 (2006.01); A61K 31/423 (2006.01); C07D 217/02 (2006.01); A61K 31/5025 (2006.01); A61K 31/517 (2006.01); C07D 237/28 (2006.01); C07D 495/04 (2006.01); C07C 311/08 (2006.01); A61K 31/437 (2006.01); C07D 491/048 (2006.01); C07D 487/02 (2006.01); C07D 277/66 (2006.01); C07D 265/36 (2006.01); C07D 235/06 (2006.01); C07D 263/52 (2006.01);
U.S. Cl.
CPC ...
C07D 263/56 (2013.01); A61K 31/416 (2013.01); A61K 31/4162 (2013.01); A61K 31/423 (2013.01); A61K 31/428 (2013.01); A61K 31/437 (2013.01); A61K 31/4365 (2013.01); A61K 31/4375 (2013.01); A61K 31/498 (2013.01); A61K 31/502 (2013.01); A61K 31/5025 (2013.01); A61K 31/517 (2013.01); A61K 31/536 (2013.01); A61K 31/5383 (2013.01); A61K 45/06 (2013.01); C07C 311/08 (2013.01); C07D 217/02 (2013.01); C07D 231/56 (2013.01); C07D 235/06 (2013.01); C07D 237/28 (2013.01); C07D 239/74 (2013.01); C07D 241/42 (2013.01); C07D 263/52 (2013.01); C07D 265/16 (2013.01); C07D 265/36 (2013.01); C07D 277/66 (2013.01); C07D 277/68 (2013.01); C07D 471/04 (2013.01); C07D 487/02 (2013.01); C07D 487/04 (2013.01); C07D 491/048 (2013.01); C07D 495/04 (2013.01); C07D 498/04 (2013.01);
Abstract

The present disclosure relates to compounds of formula (I) that are useful as modulators of α7 nAChR, compositions comprising such compounds, and the use of such compounds for preventing, treating, or ameliorating disease, particularly disorders of the central nervous system such as cognitive impairments in Alzheimer's disease, Parkinson's disease, and schizophrenia, as well as for L-DOPA induced-dyskinesia and inflammation.


Find Patent Forward Citations

Loading…